Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
180.88
+0.53 (+0.29%)
Streaming Delayed Price
Updated: 10:43 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
52
53
Next >
Decoding AbbVie's Options Activity: What's the Big Picture?
December 14, 2023
Via
Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
Buy these distressed names now and ride their share prices higher over the coming year as they stage a comeback.
Via
InvestorPlace
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 13, 2023
Via
Benzinga
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
Although some signs of economic progress is seen, other signs suggest that investors should consider defensive stock picks.
Via
InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to...
Via
Benzinga
Exposures
Product Safety
Is AbbVie Stock a Buy Now?
December 07, 2023
AbbVie's business could soon become more diversified.
Via
The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
December 05, 2023
Via
Benzinga
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
December 12, 2023
It's making a major acquisition to beef up a key area of its pipeline.
Via
The Motley Fool
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
SystImmune and Bristol Myers Squibb & Co (NYSE: BMY)
Via
Benzinga
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.
Via
Talk Markets
The 3 Best Cheap Stocks to Buy in December
December 10, 2023
Investors wanting to buy low and sell high should consider a position in one of these great companies whose shares have pulled back lately.
Via
InvestorPlace
4 Top Dividend Stocks Yielding More Than 4% to Buy Hand-Over-Fist This December
December 10, 2023
These companies offer above-average income streams that should continue rising.
Via
The Motley Fool
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?
December 10, 2023
The big drugmaker went on a holiday shopping spree.
Via
The Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
December 09, 2023
These companies and their dividends are built to last.
Via
The Motley Fool
Better Dividend Stock: AbbVie vs. Medical Properties Trust
December 09, 2023
Which of these high-yield stocks has what it takes to keep raising their payouts?
Via
The Motley Fool
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
December 08, 2023
Buying these shares can provide you with some excellent recurring income while also diversifying your portfolio.
Via
The Motley Fool
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?
December 08, 2023
Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.
Via
The Motley Fool
Healthcare Gems: 3 Essential Long-Term Stock Picks
December 07, 2023
Global healthcare spending reached a record $9 trillion in 2020. Catch the ongoing benefits with these three long-term healthcare stock picks.
Via
InvestorPlace
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
Wednesday, AbbVie Inc (NYSE: ABBV) agreed to acquire Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) for a total equity value of approximately $8.7 billion, or $45 per share in cash, with the...
Via
Benzinga
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 07, 2023
Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.
Via
Benzinga
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
Cerevel Therapeutics Holdings, Inc.
Via
Benzinga
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
December 07, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?
December 07, 2023
Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie.
Via
InvestorPlace
Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
December 07, 2023
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately...
Via
Benzinga
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
December 07, 2023
There's no guarantee that either of these big pharma stocks can help you retire as a millionaire. But one has a clear edge.
Via
The Motley Fool
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.
December 07, 2023
These particular players look cheap right now.
Via
The Motley Fool
Why Cerevel Therapeutics Holdings Is Moving After-Hours
December 06, 2023
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading higher in Wednesday's after-hours session after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity...
Via
Benzinga
7 High-Dividend Stocks to Buy for a Lifetime of Passive Income
December 06, 2023
These high-dividend stocks are among the biggest beneficiaries of current mega trends, and investors can leverage them for big gains.
Via
InvestorPlace
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch
December 06, 2023
The Russell 2000 index comprises small-cap companies, exposing investors to small organizations. Consider buying these Russell 2000 stocks.
Via
InvestorPlace
3 Stocks at the Forefront of Personalized Medicine Trend
December 05, 2023
Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
52
53
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.